Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
The SELECT trial (Lincoff et al., NEJM 2023) showed semaglutide reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease and obesity
GLP-1 medications are a class of drugs initially developed for type 2 diabetes that have demonstrated significant weight loss benefits
Most patients who came in asking for the lowest-priced jab leave choosing the regulated route once they have seen the comparison, and we are comfortable either way
Out-of-Pocket Costs Without Coverage If you don't qualify for the GLP-1 Bridge or prefer not to wait until July 2026, here's what you can expect to pay out of pocket in 2026: Approximate Monthly Costs (Without Insurance) Ozempic: ~$199-$499/month through manufacturer savings programs (list price ~$998) Wegovy: ~$149-$199/month through savings programs (list price ~$1,350) Zepbound: ~$349/month through LillyDirect (list price ~$1,060) Mounjaro: ~$349/month through LillyDirect (list price ~$1,060) Freedom and Legacy Advisors St
US$ 20.90
US$ 22.20
US$ 28.82
US$ 21.11
US$ 25.82
US$ 29.39
